Settings8H · net · $10k
LanguageThe language of the site
FundingPeriod funding rates are shown in
UnitsPercent or basis points
CostsCount taker fees and slippage in Net
SizePosition per leg used for Net and slippage
ExchangesWhich exchanges to include everywhere
My profile →
My profile
Backtest 30d
LegExchangePriceFund. /8hEach paymentNext inOIVol 24hLev
LONG119.45+0.0416pay 0.0052% / 1h52m 47s$391K$633K20xLong Popdex
SHORT119.96+0.0033get 0.0004% / 1h52m 47s$40K$133K25xShort Injective
Price gap+0.427%
Funding gap−0.0383% /8h

The gap pays +$36 on $10k if it goes back to its 7d average, but funding costs $11 a day and eats that in about 3.2 days. At the last 7 days' pace that is about 34 days.

If you open now and hold

on $10k a leg · figures of the last 7D, not a forecast
Funding−$6−0.0383% /8h now · paid −0.063% over the last 6 days (all we have)
Price+$36spread +0.427% now, avg +0.063% → +0.363% if it goes back
Costs−$690.688% of $10k · taker + slippage, in and out

The current funding rate is far below what this pair has been paying: over the last 6 days it paid −0.063% in total, about −0.0036%/8h on average.

Funding history

you earnyou payavg
RANGE STATS · 7D
Average /8h—
Highest—
Lowest—
Paid you—

Short leg rate minus long leg rate, per 8h. Above zero: the pair pays you.

Price spread between the two exchanges

Injective price against Popdexnow
RANGE STATS · 7D
Now+0.427%
Average—
Range—
Wider than now—

Where the spread has been, last 7D

share of time at each level

Funding on every exchange

/8h

HOOD on 31 exchanges

lowest funding first

Before you open

3 ok · 2 to watch
  • Watch: Large against open interest7.3 / 8.0 bp
    $10k is over 10% of Injective’s open interest.
  • Note: Margin at max leverage$500 + $400
    Popdex 20x, Injective 25x. Keep about 2× this so a sharp move doesn’t liquidate one leg.
  • OK: Same payment interval1h / 1h
    Both legs pay at the same time.
    Next 24h at the current rates, on $10k a leg: −$11.48Long Popdex: 24 payments, −$12.48; short Injective: 24 payments, +$1.00.
  • OK: Entry gap works for you+0.427% vs +0.063%
    You short the dearer leg. If the gap goes back to average, the short gains.
  • Watch: Short leg is thinner$40K vs $391K OI
    Injective sets your exit cost. Check its book before closing.
  • Note: No points program—
    Neither exchange runs points right now.
  • OK: No KYC on either legPopdex No · Injective No
    Both exchanges let you trade without ID.

Profit calculator

both legs, in and out
Position, each leg
Hold for
Orders
Price spread
Funding rate
Funding earned−0.0036%/8h × 21 periods−$7.50
Price spread+0.427% → +0.063% (7d avg)+$36.35
Slippage, 4 orderslive order books−$62.34
Fee Popdex bp × 2 orders−$6.40
Fee Injective bp × 2 orders−$0.02
Net · 7 days · $10k−$39.91
Costs to cover0.688%Break-evennever at this rate
Slippage: Popdex: live order book, 31 min ago; Injective: live order book, 41 min ago

Cost to enter

taker + slippage from mid, one side
BUY · LONGPopdex0.847.3 bp−$712.4 bp−$124doesn’t fitdoesn’t fit
SELL · SHORTInjective7.988.0 bp−$8doesn’t fitdoesn’t fitdoesn’t fit

Closing costs about the same again.

Alert

HOOD news

posts that mention HOOD or Robinhood Markets, from every exchangeSearch all news →
09-28 18:50AevoOtherbitcoin:native is back near $83k after trading above $86k last week. Whether you trade the continuation or pullback, all options and this week’s Perp Majors count toward the volume requirement for our year-end reward. This week’s Perp Majors include: BTC, ETH, SOL, ZEC, NEAR, HYPE, LIT, SPY, QQQ, HOOD, SNDK, MU, NVDA, TSLA, GOOGL. @aevoxyz on X ↗
09-21 16:05AevoContestbitcoin:native broke $85k, zcash:native crossed $1.5k, and near:native is up 70%+ in 7 days. Trading them adds volume to Aevo’s year-end leaderboard for the projected 808,800 USDC reward. Options count too, as do the other Perp Majors: ETH, SOL, HYPE, LIT, SPY, QQQ, HOOD, SNDK, MU, NVDA, TSLA, GOOGL. @aevoxyz on X ↗
09-21 13:35gTrade (Gains Network)Listingnew market HOOD/USD ($HOOD) seen by our collector
09-19 00:09SoDEXOtherRobinhood (HOOD) shares are up 9.12% today. The company has grown beyond its commission-free trading roots, expanding across options, crypto, retirement products, and subscription services while building a broader retail investing ecosystem. Explore our latest research on Robinhood, its growth strategy, and what could drive the company next: @sodex_official on X ↗
09-18 17:30Vest MarketsOther$COIN is rebounding from Tuesday's Senate defeat of the CLARITY Act, up around 12% on the session. The SEC issued a five-year innovation exemption that allows tokenized versions of U.S. stocks to trade on blockchain venues, with a comment period open. Crypto-linked equities are broadly higher, with $MSTR, $HOOD and $CRCL also up on the session. @VestExchange on X ↗
09-17 09:45RISExOther→ $ARB: → $HOOD: @risextrade on X ↗